{"id":77412,"date":"2016-03-14T13:12:00","date_gmt":"2016-03-14T13:12:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/"},"modified":"2016-03-14T13:12:00","modified_gmt":"2016-03-14T13:12:00","slug":"les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/","title":{"rendered":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#8217;entre 35 i 74 anys"},"content":{"rendered":"<p>\u00a0<\/p>\n<div><u><strong>14 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc Cardiovascular<br type=\"_moz\"><\/strong><\/u><\/div>\n<ul>\n<li><strong>Ho han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 <\/strong><\/li>\n<li><strong>Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% alt o molt alt<\/strong><br \/>\u00a0<\/li>\n<\/ul>\n<p><i>Barcelona, 14 de mar\u00e7 de 2016.- <\/i><b>M\u00e9s de 290 farm\u00e0cies de Barcelona han realitzat 205 proves per identificar factors de risc cardiovascular en persones d\u2019entre 35 i 74 anys i estratificar a 10 anys el risc de patir una malaltia coron\u00e0ria.<\/b><span> Ho han fet en el marc del programa <\/span><b>Farmacardio,<\/b><span> que va n\u00e9ixer al mar\u00e7 de 2014 fruit d\u2019un conveni de col\u00b7laboraci\u00f3 entre el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) i M\u00fatua General de Catalunya (MGC). <\/span><b>Despr\u00e9s de l\u2019\u00e8xit de la prova pilot, realitzada al districte barcelon\u00ed de Sarri\u00e0-Sant Gervasi, al novembre de 2015 es va estendre a tota la prov\u00edncia<\/b><span>, amb la incorporaci\u00f3 de la Fundaci\u00f3 M\u00fatua General de Catalunya i COFBServeis.<\/span><\/p>\n<p><span>Per veure el <a href=\"https:\/\/www.youtube.com\/watch?v=gSNUW9f6ANI\" target=\"_blank\" rel=\"noopener\">v\u00eddeo,<\/a> fes clic a la <a href=\"https:\/\/www.youtube.com\/watch?v=gSNUW9f6ANI\" target=\"_blank\" rel=\"noopener\">imatge<\/a>:<\/span><\/p>\n<p class=\"MsoNormal\"><a href=\"https:\/\/www.youtube.com\/watch?v=gSNUW9f6ANI\" target=\"_blank\" rel=\"noopener\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.cofb.org\/image\/image_gallery?uuid=74383b01-5741-4212-819b-0a14535fa949&amp;groupId=10136&amp;t=1457957771804\" width=\"365\" height=\"159\" alt=\"\"><\/a>\u00a0<\/p>\n<p class=\"MsoNormal\"><b><u>Dels pacients atesos, un 6,83% han presentat un risc cardiovascular alt o molt alt<\/u><\/b><u><\/p>\n<p><\/u><\/p>\n<p class=\"MsoNormal\">Del total de pacients atesos, <b>el 71,70% (147)<\/b> <b>amb un factor de risc baix<\/b> i el <b>21,46% (44) amb un risc moderat <\/b>es van derivar al metge de cap\u00e7alera; i amb el <b>6,83%<\/b> <b>(14)<\/b> amb un resultat<b> de risc alt o molt alt, <\/b>un cop van rebre l\u2019informe m\u00e8dic,<b> <\/b>se\u2019ls va derivar a una unitat especialitzada. <span><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\"><b><u>Com funciona la prova?<\/p>\n<p><\/u><\/b><\/p>\n<p class=\"MsoNormal\"><b>Els resultats es poden extreure a partir de les proves espec\u00edfiques que realitza el farmac\u00e8utic<\/b> \u2013format pr\u00e8viament per realitzar-les\u2013 que permeten <b>mesurar els factors de risc cardiovascular en persones sense cap antecedent personal de malaltia d\u2019origen cardiovascular diagnosticada per un metge<\/b> (malaltia coron\u00e0ria, vascular cerebral o arterial perif\u00e8rica). Els factors que analitza, en no m\u00e9s de 30 minuts, s\u00f3n l\u2019h\u00e0bit tab\u00e0quic, l\u2019edat, el sexe, la tensi\u00f3 arterial, la xifra de colesterol\u00e8mia, l\u2019IMC (\u00cdndex de Massa Corporal) i els possibles antecedents personals de diabetis mellitus diagnosticada, aix\u00ed com la xifra de glic\u00e8mia capil\u00b7lar, el per\u00edmetre abdominal i l\u2019\u00edndex cintura\/maluc. <b>Al finalitzar-les, entrega a l\u2019usuari els resultats de les proves realitzades i un fullet\u00f3 amb informaci\u00f3 i consells per dur h\u00e0bits de vida saludables<\/b>. Al seu torn, <b>en un termini de 4 dies, l\u2019equip m\u00e8dic de M\u00fatua General de Catalunya envia a l\u2019usuari <\/b>per correu electr\u00f2nic un <b>informe a partir dels resultats analitzats i una proposta d\u2019actuaci\u00f3 individualitzada en funci\u00f3 del risc detectat.<\/p>\n<p><\/b><\/p>\n<p class=\"MsoNormal\">Les <b>farm\u00e0cies que ofereixen el servei estan identificades amb un distintiu <\/b>i tamb\u00e9 es poden localitzar a trav\u00e9s del web <b><a href=\"http:\/\/farmacardio.com\/es\">farmacardio.com<\/a><\/b>, des d\u2019on es pot adquirir el cup\u00f3 de compra del servei a un preu de 58\u20ac. Per als mutualistes amb asseguran\u00e7a de salut, en edats\u00a0 compreses entre 35 i 74 anys, el servei \u00e9s gratu\u00eft.<\/p>\n<p class=\"MsoNormal\">\n<p class=\"MsoNormal\">Es tracta d\u2019un <b>projecte pioner a Espanya, <\/b>doncs \u00e9s el<b> primer cop que una entitat asseguradora privada compta amb el farmac\u00e8utic com a professional decisiu per intervenir en el desenvolupament d\u2019activitats preventives. <\/b>De fet, gr\u00e0cies a la proximitat i accessibilitat de les farm\u00e0cies, un dels aspectes que han valorat positivament els usuaris, es pot aconseguir una major incid\u00e8ncia en <b>un dels p\u00fablics principals del programa: persones que, per la seva edat, aparentment no tenen cap problema de salut o no acudeixen al metge de forma habitual, per\u00f2 que poden ser, en canvi, poblaci\u00f3 amb risc cardiovascular.<\/b><\/p>\n<p class=\"MsoNormal\"><u><b>Per a m\u00e9s informaci\u00f3:<\/b><\/u><\/p>\n<p><b>Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona <br \/><\/b>premsa@cofb.net \/ 93 244 07 28\/18<\/p>\n<p><b>M\u00fatua General de Catalunya<br \/><\/b>Marta Escartin  <br \/>mescartin@mgc.es \/ 93 414 36 00<b><\/p>\n<p><\/b><\/p>\n<p>\u00a014 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc CardiovascularHo han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% alt o molt alt\u00a0Barcelona, 14 de mar\u00e7 de 2016.- M\u00e9s de 290 farm\u00e0cies de Barcelona han realitzat 205 proves per identificar factors de risc cardiovascular en persones d\u2019entre 35 i 74 anys i estratificar a 10 anys el risc de patir una malaltia coron\u00e0ria. Ho han fet en el marc del programa Farmacardio, que va n\u00e9ixer al mar\u00e7 de 2014 fruit d\u2019un conveni de col\u00b7laboraci\u00f3 entre el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) i M\u00fatua General de Catalunya (MGC). Despr\u00e9s de l\u2019\u00e8xit de la prova pilot, realitzada al districte barcelon\u00ed de Sarri\u00e0-Sant Gervasi, al novembre de 2015 es va estendre a tota la prov\u00edncia, amb la incorporaci\u00f3 de la Fundaci\u00f3 M\u00fatua General de Catalunya i COFBServeis.Per veure el v\u00eddeo, fes clic a la imatge:\u00a0Dels pacients atesos, un 6,83% han presentat un risc cardiovascular alt o molt altDel total de pacients atesos, el 71,70% (147) amb un factor de risc baix i el 21,46% (44) amb un risc moderat es van derivar al metge de cap\u00e7alera; i amb el 6,83% (14) amb un resultat de risc alt o molt alt, un cop van rebre l\u2019informe m\u00e8dic, se\u2019ls va derivar a una unitat especialitzada. Com funciona la prova?Els resultats es poden extreure a partir de les proves espec\u00edfiques que realitza el farmac\u00e8utic \u2013format pr\u00e8viament per realitzar-les\u2013 que permeten mesurar els factors de risc cardiovascular en persones sense cap antecedent personal de malaltia d\u2019origen cardiovascular diagnosticada per un metge (malaltia coron\u00e0ria, vascular cerebral o arterial perif\u00e8rica). Els factors que analitza, en no m\u00e9s de 30 minuts, s\u00f3n l\u2019h\u00e0bit tab\u00e0quic, l\u2019edat, el sexe, la tensi\u00f3 arterial, la xifra de colesterol\u00e8mia, l\u2019IMC (\u00cdndex de Massa Corporal) i els possibles antecedents personals de diabetis mellitus diagnosticada, aix\u00ed com la xifra de glic\u00e8mia capil\u00b7lar, el per\u00edmetre abdominal i l\u2019\u00edndex cintura\/maluc. Al finalitzar-les, entrega a l\u2019usuari els resultats de les proves realitzades i un fullet\u00f3 amb informaci\u00f3 i consells per dur h\u00e0bits de vida saludables. Al seu torn, en un termini de 4 dies, l\u2019equip m\u00e8dic de M\u00fatua General de Catalunya envia a l\u2019usuari per correu electr\u00f2nic un informe a partir dels resultats analitzats i una proposta d\u2019actuaci\u00f3 individualitzada en funci\u00f3 del risc detectat.Les farm\u00e0cies que ofereixen el servei estan identificades amb un distintiu i tamb\u00e9 es poden localitzar a trav\u00e9s del web farmacardio.com, des d\u2019on es pot adquirir el cup\u00f3 de compra del servei a un preu de 58\u20ac. Per als mutualistes amb asseguran\u00e7a de salut, en edats\u00a0 compreses entre 35 i 74 anys, el servei \u00e9s gratu\u00eft.Es tracta d\u2019un projecte pioner a Espanya, doncs \u00e9s el primer cop que una entitat asseguradora privada compta amb el farmac\u00e8utic com a professional decisiu per intervenir en el desenvolupament d\u2019activitats preventives. De fet, gr\u00e0cies a la proximitat i accessibilitat de les farm\u00e0cies, un dels aspectes que han valorat positivament els usuaris, es pot aconseguir una major incid\u00e8ncia en un dels p\u00fablics principals del programa: persones que, per la seva edat, aparentment no tenen cap problema de salut o no acudeixen al metge de forma habitual, per\u00f2 que poden ser, en canvi, poblaci\u00f3 amb risc cardiovascular.Per a m\u00e9s informaci\u00f3:Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona premsa@cofb.net \/ 93 244 07 28\/18M\u00fatua General de CatalunyaMarta Escartin  mescartin@mgc.es \/ 93 414 36 00\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 14 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc Cardiovascular Ho han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":77413,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#039;entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#039;entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 14 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc Cardiovascular Ho han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-14T13:12:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1587\" \/>\n\t<meta property=\"og:image:height\" content=\"691\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#8217;entre 35 i 74 anys\",\"datePublished\":\"2016-03-14T13:12:00+00:00\",\"dateModified\":\"2016-03-14T13:12:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\"},\"wordCount\":1276,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg\",\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\",\"name\":\"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d'entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg\",\"datePublished\":\"2016-03-14T13:12:00+00:00\",\"dateModified\":\"2016-03-14T13:12:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg\",\"width\":1587,\"height\":691},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#8217;entre 35 i 74 anys\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d'entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/","og_locale":"ca_ES","og_type":"article","og_title":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d'entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 14 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc Cardiovascular Ho han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-03-14T13:12:00+00:00","og_image":[{"width":1587,"height":691,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#8217;entre 35 i 74 anys","datePublished":"2016-03-14T13:12:00+00:00","dateModified":"2016-03-14T13:12:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/"},"wordCount":1276,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg","articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/","url":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/","name":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d'entre 35 i 74 anys - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg","datePublished":"2016-03-14T13:12:00+00:00","dateModified":"2016-03-14T13:12:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg","width":1587,"height":691},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/03\/14\/les-farmacies-de-barcelona-han-realitzat-mes-de-200-proves-per-identificar-factors-de-risc-cardiovascular-en-persones-dentre-35-i-74-anys\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Les farm\u00e0cies de Barcelona han realitzat m\u00e9s de 200 proves per identificar factors de risc cardiovascular en persones d&#8217;entre 35 i 74 anys"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg",1587,691,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-150x150.jpeg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-300x131.jpeg",300,131,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-768x334.jpeg",768,334,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-1024x446.jpeg",1024,446,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-1536x669.jpeg",1536,669,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0.jpeg",1587,691,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2016\/03\/image_gallery-io4ZH0-18x8.jpeg",18,8,true]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 14 de mar\u00e7: Dia Europeu de la Prevenci\u00f3 del Risc Cardiovascular Ho han fet el marc del programa Farmacardio, que es va estendre a tota la prov\u00edncia de Barcelona al novembre de 2015 Dels pacients atesos, un 71,70% van presentar risc cardiovascular baix; el 21,46% moderat; i el 6,83% [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77412"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/77413"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}